Stockreport

SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), [Read more]